[AI generated] FibroGen, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies to treat serious unmet medical needs. The company focuses on areas such as fibrosis and oncology, with its lead product candidates targeting conditions like chronic kidney disease and anemia. FibroGen harnesses innovative technologies to develop first-in-class therapeutics.